/C O R R E C T I O N -- Pegasus/PBN Pharmacal/

In the news release, Liavium®-CA1 (pregabalin chewable tablets) Receives FDA Conditional Approval, Redefining Canine Neuropathic Pain Care, issued 18-May-2026 by Pegasus/PBN Pharmacal over PR Newswire, we are advised by the company that changes have been made. The complete, corrected...